On 2024-11-22, Addex Therapeutics Ltd. Sponsored ADR (ADXN) announced earnings per share of $-2.77 for the fiscal quarter ending 2024-09-30, missing the average analyst estimate of $-1.40.
The next expected annoucement date for quarterly earnings is 2025-04-17, with an average estimated earnings per share of $-1.40 for the fiscal quarter ending 2024-12-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-11-22 | 2024-09-30 | $-1.40 | $-2.77 |
| 2024-09-30 | 2024-06-30 | $-0.07 | $-1.77 |
| 2024-06-06 | 2024-03-31 | -- | $-1.37 |
| 2024-04-18 | 2023-12-31 | -- | $-4.06 |
| 2023-11-29 | 2023-09-30 | $-4.00 | $-4.07 |
| 2023-08-10 | 2023-06-30 | -- | $-5.00 |
| 2023-05-11 | 2023-03-31 | -- | $-5.20 |
| 2023-03-30 | 2022-12-31 | -- | $-5.00 |
| 2022-11-11 | 2022-09-30 | $-11.20 | $-11.20 |
| 2022-08-18 | 2022-06-30 | $-11.20 | $-23.60 |
| 2022-05-05 | 2022-03-31 | $-10.40 | $-19.40 |
| 2022-03-10 | 2021-12-31 | $-13.20 | $-16.60 |
| 2021-11-04 | 2021-09-30 | $-14.40 | $-14.40 |
| 2021-08-05 | 2021-06-30 | $-13.00 | $-15.40 |
| 2021-05-05 | 2021-03-31 | $-13.00 | $-10.60 |
| 2021-03-11 | 2020-12-31 | -- | $-10.60 |
| 2020-11-03 | 2020-09-30 | -- | $-15.60 |
| 2020-08-12 | 2020-06-30 | -- | $-15.00 |
| 2020-05-20 | 2020-03-31 | -- | $-19.80 |